Trial
NCT05999708
A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Colitis, Ulcerative
Intervention
GSK4381406
Why stopped
Study terminated prior to FSFV for strategic business reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-15